Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|May 24, 2022
Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIVEthan D Valinetz, Daniel Matemo, Jill K Gersh, et al.
Journal of Clinical Microbiology|March 14, 2024
Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB UltimaRachel C Wood, Angelique K Luabeya, Rane B Dragovich, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2010
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newbornsBenjamin M N Kagina, Brian Abel, Thomas J Scriba, et al.
Vaccine|November 22, 2016
H1:IC31 vaccination is safe and induces long-lived TNF-α<sup>+</sup>IL-2<sup>+</sup>CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.
American Journal of Respiratory and Critical Care Medicine|January 6, 2021
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis InfectionCheleka A M Mpande, Munyaradzi Musvosvi, Virginie Rozot, et al.
Vaccine|October 23, 2023
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled TrialElisa Nemes, Anneke C Hesseling, Michele Tameris, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2023
Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteriaMelissa Murphy, Sara Suliman, Libby Briel, et al.
The Pediatric Infectious Disease Journal|August 8, 2015
Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected ChildrenKany Kany A Luabeya, Michele D Tameris, Hennie D Geldenhuys, et al.
Communications Medicine|March 28, 2022
Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCRSimon C Mendelsohn, Stanley Kimbung Mbandi, Andrew Fiore-Gartland, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|May 24, 2022
Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIVEthan D Valinetz, Daniel Matemo, Jill K Gersh, et al.
Journal of Clinical Microbiology|March 14, 2024
Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB UltimaRachel C Wood, Angelique K Luabeya, Rane B Dragovich, et al.
American Journal of Respiratory and Critical Care Medicine|June 19, 2010
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newbornsBenjamin M N Kagina, Brian Abel, Thomas J Scriba, et al.
Vaccine|November 22, 2016
H1:IC31 vaccination is safe and induces long-lived TNF-α<sup>+</sup>IL-2<sup>+</sup>CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.
American Journal of Respiratory and Critical Care Medicine|January 6, 2021
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis InfectionCheleka A M Mpande, Munyaradzi Musvosvi, Virginie Rozot, et al.
Vaccine|October 23, 2023
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled TrialElisa Nemes, Anneke C Hesseling, Michele Tameris, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2023
Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteriaMelissa Murphy, Sara Suliman, Libby Briel, et al.
The Pediatric Infectious Disease Journal|August 8, 2015
Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected ChildrenKany Kany A Luabeya, Michele D Tameris, Hennie D Geldenhuys, et al.
Communications Medicine|March 28, 2022
Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCRSimon C Mendelsohn, Stanley Kimbung Mbandi, Andrew Fiore-Gartland, et al.
Pageof 23